These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5567724)

  • 1. Erwinia species from human sources.
    Tilton RC; Murphy JR; van Soestbergen A
    Am J Clin Pathol; 1971 Aug; 56(2):187-92. PubMed ID: 5567724
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and bacteriologic observations on the proposed species, Enterobacter agglomerans (the Herbicola-Lathyri bacteria).
    Pien FD; Martin WJ; Hermans PE; Washington JA
    Mayo Clin Proc; 1972 Oct; 47(10):739-45. PubMed ID: 4344106
    [No Abstract]   [Full Text] [Related]  

  • 3. Erwinia species: an emerging human pathogen.
    Bottone E; Schneierson SS
    Am J Clin Pathol; 1972 Mar; 57(3):400-5. PubMed ID: 5018609
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of Erwinia in the vagina as causative agents of urinary tract infections.
    Umenai T; Saitoh Y; Takano S; Shoji E; Tanaka K; Ishida N
    Tohoku J Exp Med; 1979 Sep; 129(1):103-4. PubMed ID: 494253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temocillin susceptibility by BSAC methodology.
    Andrews JM; Jevons G; Walker R; Ashby J; Fraise AP
    J Antimicrob Chemother; 2007 Jul; 60(1):185-7. PubMed ID: 17550891
    [No Abstract]   [Full Text] [Related]  

  • 6. Gonococcal pharyngeal infections. Report of 110 cases.
    Bro-Jorgensen A; Jensen T
    Br J Vener Dis; 1973 Dec; 49(6):491-9. PubMed ID: 4202719
    [No Abstract]   [Full Text] [Related]  

  • 7. A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome.
    de Maio Carrilho CM; de Oliveira LM; Gaudereto J; Perozin JS; Urbano MR; Camargo CH; Grion CM; Levin AS; Costa SF
    BMC Infect Dis; 2016 Nov; 16(1):629. PubMed ID: 27809803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacterial flora and its sensitivity to antibiotics in urinary tract infections in children].
    Szozda G; Nowakowska K
    Probl Med Wieku Rozwoj; 1984; 13():59-67. PubMed ID: 6442420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary infections by enterobacteriaceae resistent to antimicrobial agents].
    Ales Reinlein JM; Vela Navarrete R; Fernández Puentes MC; Silva M
    Rev Clin Esp; 1973 Aug; 130(4):295-300. PubMed ID: 4755593
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study.
    Cuevas O; Cercenado E; Gimeno M; Marín M; Coronel P; Bouza E;
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):251-60. PubMed ID: 20542206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human pharmacology and clinical evaluation of an oral carbenicillin preparation.
    Bran JL; Karl DM; Kaye D
    Clin Pharmacol Ther; 1971; 12(3):525-30. PubMed ID: 5208911
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of Clinical and Laboratory Standards Institute breakpoint changes on susceptibility rates of cephalosporins in uncomplicated urinary tract infections caused by Enterobacteriaceae.
    Bunnell KL; Wenzler E; Harrington AT; Danziger LH
    Diagn Microbiol Infect Dis; 2018 Apr; 90(4):335-336. PubMed ID: 29395714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human infection caused by an Erwinia species.
    Slotnick IJ; Tulman L
    Am J Med; 1967 Jul; 43(1):147-50. PubMed ID: 4951415
    [No Abstract]   [Full Text] [Related]  

  • 14. Resistance patterns of Enterobacteriaceae in urines are similar in symptomatic and asymptomatic patients.
    Romero Palacios A; Al Dhufairi F; Ellis C; Smyth D; Mieusement LMD; McGeer A; Mertz D
    J Hosp Infect; 2018 Aug; 99(4):419-421. PubMed ID: 29432819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimicrobial susceptibility in urinary tract infections caused by ESBL- and non-ESBL-producing Enterobacteriaceae in hospitalized/outpatient-, sex-, age-matched patients].
    Jaqueti-Aroca J; Molina-Esteban L; Limón-Yelmo A; García-Arata I
    Rev Esp Quimioter; 2018 Feb; 31(1):63-65. PubMed ID: 29390602
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections: a central military hospital study.
    Timko J
    Chin Med J (Engl); 2014; 127(23):4150-1. PubMed ID: 25430467
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the effect of amoxycillin and ampicillin on Enterobacteriaceae in an experimental model of urinary infection.
    Anderson JD; Warner M; Forshaw HL
    J Antimicrob Chemother; 1975 Jun; 1(2):197-204. PubMed ID: 1165231
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica-Doboj Canton, Bosnia and Herzegovina.
    Uzunovic-Kamberovic S
    J Antimicrob Chemother; 2006 Aug; 58(2):344-8. PubMed ID: 16775214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of amoxycillin--a new semisynthetic penicillin.
    Sabto J; Carson P; Morgan T
    Med J Aust; 1973 Sep; 2(11):537-41. PubMed ID: 4748581
    [No Abstract]   [Full Text] [Related]  

  • 20. Emergence of multiple carbapenemase-producing organisms in single patients: an increasing threat to treatment of infection.
    An J; Lai K; Ma Y; Guo L; Ye L; Luo Y; Yang J
    J Antimicrob Chemother; 2018 Feb; 73(2):544-546. PubMed ID: 29136151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.